MENLO PARK, Calif.--(BUSINESS WIRE)--iSchemaView, the worldwide leader in advanced imaging for stroke, has received approval from ANVISA (the Brazilian Health Regulatory Agency), for the use of the ...
MENLO PARK, Calif.--(BUSINESS WIRE)--iSchemaView, the worldwide leader in advanced imaging for stroke, today announced that the FDA has cleared the RAPID neuroimaging platform for use in selecting ...
RapidAI has secured an FDA clearance for its artificial intelligence algorithms that quickly parse brain CT scans and spot suspected large vessel occlusions, the cause of fatal or debilitating strokes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results